Your browser doesn't support javascript.
loading
Effects of briakinumab treatment for moderate to severe psoriasis on health-related quality of life and work productivity and activity impairment: results from a randomized phase III study.
Papp, K A; Sundaram, M; Bao, Y; Williams, D A; Gu, Y; Signorovitch, J E; Wang, Y; Valdes, J M; Mulani, P M.
Affiliation
  • Papp KA; Probity Medical Research, Waterloo, Ontario, Canada.
J Eur Acad Dermatol Venereol ; 28(6): 790-8, 2014 Jun.
Article in En | MEDLINE | ID: mdl-23679896
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Quality of Life / Efficiency / Antibodies, Monoclonal Type of study: Clinical_trials Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2014 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Quality of Life / Efficiency / Antibodies, Monoclonal Type of study: Clinical_trials Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2014 Document type: Article Affiliation country: